Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 4.58%
- Poor long term growth as Net Sales has grown by an annual rate of 17.80% and Operating profit at 16.63% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.08
2
Flat results in Dec 24
3
With ROE of 8.93%, it has a Expensive valuation with a 0.90 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.92%
0%
-26.92%
6 Months
-44.12%
0%
-44.12%
1 Year
-22.45%
0%
-22.45%
2 Years
222.03%
0%
222.03%
3 Years
153.33%
0%
153.33%
4 Years
100.0%
0%
100.0%
5 Years
192.31%
0%
192.31%
Nanjing Sinolife United Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.80%
EBIT Growth (5y)
16.63%
EBIT to Interest (avg)
-12.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
1.17
Tax Ratio
15.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.21%
ROE (avg)
4.58%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.90
EV to EBIT
6.11
EV to EBITDA
4.53
EV to Capital Employed
0.87
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.22%
ROE (Latest)
8.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
623.20
319.60
94.99%
Operating Profit (PBDIT) excl Other Income
78.70
2.80
2,710.71%
Interest
3.60
0.50
620.00%
Exceptional Items
0.00
-2.00
100.00%
Consolidate Net Profit
58.10
-16.60
450.00%
Operating Profit Margin (Excl OI)
101.90%
-45.60%
14.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 94.99% vs 5.10% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 450.00% vs 56.54% in Dec 2022
About Nanjing Sinolife United Co., Ltd. 
Nanjing Sinolife United Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






